Announcements

Advanced Search
  • Feb 11, 2021

    DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2020. For the full year diluted earnings per share from continuing operations was...

  • Jan 29, 2021

    DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 11, 2021, at 5:00 p.m. Eastern Time. The company...

  • Dec 22, 2020
    Milestone underscores company's 20-year commitment to pursuing optimal patient outcomes

    Today, DaVita Kidney Care announced that more than 100,000 DaVita patients have received a kidney transplant since 2000. This milestone represents the culmination of two decades of innovative...

  • Nov 24, 2020
    DaVita expands its giving platform and community support

    DENVER, Nov. 24, 2020–DaVita Inc., a leading provider of kidney care services in the U.S. demonstrates its commitment to supporting healthy communities via its annual giving program, DaVita Way...

  • Nov 23, 2020
    Event goes virtual in 2020 to raise awareness of kidney health and support global COVID-19 protection efforts

    DaVita Inc. today announced its annual cycling event, Tour DaVita, raised nearly $1 million to benefit Bridge of Life, a nonprofit founded by DaVita that is focused on strengthening health care...

  • Nov 4, 2020

    DaVita Kidney Care, a leading provider of kidney care services in the United States, issued the following statement: "We are grateful that Californians voted down Proposition 23, a harmful ballot...

  • Oct 29, 2020

    DaVita Inc. (NYSE: DVA) announced financial and operating results for the third quarter ended September 30, 2020. During the quarter, notwithstanding the challenges of responding to COVID-19, the...

  • Oct 22, 2020
    Latest research supports improvements in care delivery and patient outcomes

    DaVita Clinical Research (DCR) will present 14 research abstracts from company representatives and medical professionals at the American Society of Nephrology (ASN) annual Kidney Week occurring...

  • Oct 15, 2020

    DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Thursday, October 29, 2020, at 5:00 p.m. Eastern Time. The company...

  • Sep 21, 2020
    Bipartisan, bicameral legislation would improve quality of life for patients with kidney disease

    DaVita joins Dialysis Patient Citizens in supporting BETTER Kidney Care Act Bipartisan, bicameral legislation would improve quality of life for patients with kidney disease DaVita joins...

  • Sep 17, 2020

    DAVITA INC. (NYSE: DVA) ("DaVita") a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care...

  • Sep 15, 2020

    DAVITA INC. (NYSE: DVA) ("DaVita"), a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care...

  • Sep 8, 2020

    DaVita Inc. announced today that its Board of Directors appointed a new independent director, Mr. Shawn Guertin, to join the Board, effective Sept. 15. Mr. Guertin joins the Board with nearly 35...

  • Aug 27, 2020
    DaVita urges patients to have an emergency plan in place for dialysis treatment

    In response to Hurricane Laura, DaVita Kidney Care has opened its dialysis centers in Texas, Louisiana, Alabama and Mississippi to anyone who needs treatment, regardless of where those patients...

  • Aug 20, 2020
    DaVita Clinical Research investigating presence of COVID-19 antibodies and genetic contributions to infection severity in patients

    DaVita Clinical Research (DCR), a subsidiary of DaVita Inc., has begun enrollment on two clinical research trials to study how COVID-19 affects people with end stage kidney disease (ESKD) who are...

  • Aug 17, 2020

    DaVita Inc. (NYSE: DVA) ("DaVita"), a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care...

  • Aug 13, 2020
    The "Bridge to Your Dreams" program offers DaVita clinical teammates the opportunity to receive financial support to help them earn nursing degrees

    DaVita has expanded a tuition and support program for its clinical teammates to help them earn an associate's degree in nursing. The program, named Bridge to Your Dreams, includes comprehensive...

  • Aug 11, 2020

    DaVita Inc. (NYSE: DVA) announced today that its Board of Directors appointed a new independent director, Ms. Paula A. Price, to join the Board, effective September 1, 2020. "We are very excited...

  • Aug 6, 2020

    DaVita Inc. (NYSE: DVA) ("DaVita") announced today the pricing of its previously announced private offering of $1.5 billion aggregate principal amount of senior notes due 2031 (the "2031 notes")....

  • Aug 6, 2020

    DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering of $1.5 billion aggregate principal amount of senior notes due 2031 (the "2031 notes"), subject to...

  • Jul 30, 2020

    During the second quarter of 2020, DaVita (NYSE: DVA) remained focused on its top priorities, the safety and care of its patients, caregivers, teammates and physician partners. In the face of the...

  • Jul 15, 2020

    DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Thursday, July 30, 2020, at 5:00 p.m. Eastern Time. The company plans...

  • Jun 17, 2020
    Mandy Hale, DNP, MSN, MBA, RN, CNN, promoted to new clinical leadership role after 19 years of serving dialysis patients with DaVita

    DaVita Kidney Care recently announced Mandy Hale as the company's chief nursing officer. Hale most recently served as the company's vice president of nursing, overseeing more than 18,000 nurses...

  • May 28, 2020
    Dr. Thao Truong Pascual has assumed the clinical leadership role for DaVita's growing nephrology practice management arm

    Nephrology Practice Solutions (NPS) today announced that Dr. Thao Truong Pascual has assumed the role of chief medical officer (CMO). As a subsidiary of DaVita, NPS owns or manages nephrology...

  • May 26, 2020

    DaVita Inc. (NYSE: DVA) ("DaVita") announced today the pricing of its previously announced private offering of $1.75 billion aggregate principal amount of senior notes due 2030 (the "2030 notes")....

Show 5102550100 per page